Strategy Asset Managers LLC Acquires 181 Shares of The Procter & Gamble Company (NYSE:PG)

Strategy Asset Managers LLC grew its position in shares of The Procter & Gamble Company (NYSE:PGFree Report) by 4.0% during the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 4,718 shares of the company’s stock after acquiring an additional 181 shares during the quarter. Strategy Asset Managers LLC’s holdings in Procter & Gamble were worth $817,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Concurrent Investment Advisors LLC lifted its holdings in shares of Procter & Gamble by 4.5% during the 3rd quarter. Concurrent Investment Advisors LLC now owns 94,109 shares of the company’s stock valued at $16,300,000 after buying an additional 4,035 shares during the period. Radnor Capital Management LLC purchased a new stake in shares of Procter & Gamble in the 3rd quarter worth $5,705,000. Welch Group LLC increased its stake in shares of Procter & Gamble by 0.9% in the 3rd quarter. Welch Group LLC now owns 323,870 shares of the company’s stock worth $56,094,000 after purchasing an additional 2,990 shares in the last quarter. Swiss National Bank increased its stake in shares of Procter & Gamble by 0.6% in the 3rd quarter. Swiss National Bank now owns 7,005,790 shares of the company’s stock worth $1,213,403,000 after purchasing an additional 39,000 shares in the last quarter. Finally, GAMMA Investing LLC increased its stake in shares of Procter & Gamble by 67.2% in the 2nd quarter. GAMMA Investing LLC now owns 26,803 shares of the company’s stock worth $4,420,000 after purchasing an additional 10,777 shares in the last quarter. 65.77% of the stock is owned by institutional investors.

Procter & Gamble Stock Up 0.0 %

PG opened at $170.77 on Wednesday. The firm has a 50-day simple moving average of $170.07 and a two-hundred day simple moving average of $168.49. The Procter & Gamble Company has a 52 week low of $142.50 and a 52 week high of $177.94. The company has a market capitalization of $402.17 billion, a PE ratio of 29.44, a price-to-earnings-growth ratio of 3.67 and a beta of 0.42. The company has a quick ratio of 0.55, a current ratio of 0.75 and a debt-to-equity ratio of 0.50.

Procter & Gamble (NYSE:PGGet Free Report) last announced its quarterly earnings results on Friday, October 18th. The company reported $1.93 EPS for the quarter, beating analysts’ consensus estimates of $1.90 by $0.03. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The firm had revenue of $21.74 billion during the quarter, compared to the consensus estimate of $21.99 billion. During the same quarter last year, the firm earned $1.83 EPS. The firm’s revenue for the quarter was down .6% compared to the same quarter last year. Analysts forecast that The Procter & Gamble Company will post 6.94 earnings per share for the current fiscal year.

Procter & Gamble Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Friday, October 18th were issued a $1.0065 dividend. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.36%. The ex-dividend date was Friday, October 18th. Procter & Gamble’s payout ratio is 69.48%.

Analysts Set New Price Targets

Several equities research analysts have recently commented on the company. Royal Bank of Canada restated a “sector perform” rating and issued a $164.00 price objective on shares of Procter & Gamble in a research note on Monday, October 21st. DZ Bank upgraded Procter & Gamble from a “hold” rating to a “buy” rating and set a $190.00 price objective for the company in a research note on Thursday, August 29th. Piper Sandler began coverage on Procter & Gamble in a research note on Tuesday, September 24th. They issued a “neutral” rating and a $174.00 price objective for the company. StockNews.com lowered Procter & Gamble from a “buy” rating to a “hold” rating in a research note on Thursday, August 1st. Finally, Wolfe Research upgraded Procter & Gamble to a “strong-buy” rating in a research note on Friday, August 23rd. Nine equities research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $177.00.

Get Our Latest Research Report on PG

Insider Activity at Procter & Gamble

In other Procter & Gamble news, insider Balaji Purushothaman sold 12,800 shares of the firm’s stock in a transaction dated Thursday, October 24th. The shares were sold at an average price of $168.99, for a total value of $2,163,072.00. Following the completion of the sale, the insider now owns 11,566 shares of the company’s stock, valued at $1,954,538.34. This trade represents a 52.53 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Ma. Fatima Francisco sold 96,000 shares of the firm’s stock in a transaction dated Thursday, August 22nd. The stock was sold at an average price of $170.00, for a total transaction of $16,320,000.00. Following the completion of the sale, the chief executive officer now directly owns 13,721 shares of the company’s stock, valued at approximately $2,332,570. The trade was a 87.49 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 270,727 shares of company stock valued at $46,014,037. Insiders own 0.18% of the company’s stock.

Procter & Gamble Company Profile

(Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

Further Reading

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.